This company has been acquired
Augmedix Beheer
Beheer criteriumcontroles 3/4
We currently do not have sufficient information about the CEO.
Belangrijke informatie
Manny Krakaris
Algemeen directeur
US$919.1k
Totale compensatie
Percentage CEO-salaris | 49.9% |
Dienstverband CEO | 6yrs |
Eigendom CEO | 0.1% |
Management gemiddelde ambtstermijn | 4.8yrs |
Gemiddelde ambtstermijn bestuur | 3yrs |
Recente managementupdates
Recent updates
Augmedix, Inc. (NASDAQ:AUGX) Stock's 38% Dive Might Signal An Opportunity But It Requires Some Scrutiny
Jun 19Is Augmedix, Inc. (NASDAQ:AUGX) Trading At A 40% Discount?
May 21Augmedix, Inc. (NASDAQ:AUGX) Shares Slammed 29% But Getting In Cheap Might Be Difficult Regardless
Apr 25Augmedix: Secular AI Tailwinds, But Still Unattractive Risk-Reward
Mar 24Augmedix, Inc. (NASDAQ:AUGX) Just Released Its Third-Quarter Results And Analysts Are Updating Their Estimates
Nov 09Augmedix reports Q2 results
Aug 08Augmedix: A Splendid Long-Term Investing Opportunity
Jan 21Analyse CEO-vergoeding
Datum | Totale vergoeding | Salaris | Bedrijfswinsten |
---|---|---|---|
Jun 30 2024 | n/a | n/a | -US$24m |
Mar 31 2024 | n/a | n/a | -US$20m |
Dec 31 2023 | US$919k | US$459k | -US$19m |
Sep 30 2023 | n/a | n/a | -US$20m |
Jun 30 2023 | n/a | n/a | -US$21m |
Mar 31 2023 | n/a | n/a | -US$24m |
Dec 31 2022 | US$1m | US$450k | -US$24m |
Sep 30 2022 | n/a | n/a | -US$24m |
Jun 30 2022 | n/a | n/a | -US$21m |
Mar 31 2022 | n/a | n/a | -US$19m |
Dec 31 2021 | US$2m | US$400k | -US$17m |
Sep 30 2021 | n/a | n/a | -US$16m |
Jun 30 2021 | n/a | n/a | -US$17m |
Mar 31 2021 | n/a | n/a | -US$16m |
Dec 31 2020 | US$634k | US$296k | -US$16m |
Sep 30 2020 | n/a | n/a | -US$15m |
Jun 30 2020 | n/a | n/a | -US$18m |
Mar 31 2020 | n/a | n/a | -US$19m |
Dec 31 2019 | US$511k | US$350k | -US$18m |
Compensatie versus markt: Manny's total compensation ($USD919.10K) is above average for companies of similar size in the US market ($USD677.23K).
Compensatie versus inkomsten: Manny's compensation has been consistent with company performance over the past year.
CEO
Manny Krakaris (65 yo)
6yrs
Tenure
US$919,099
Compensatie
Mr. Emmanuel Krakaris, also known as Manny, is President, Secretary and Director of Augmedix, Inc. since October 2018 and is its Chief Executive Officer since October 2018. Mr. Krakaris served as the Chie...
Leiderschapsteam
Naam | Positie | Tenure | Compensatie | Eigendom |
---|---|---|---|---|
President | 6yrs | US$919.10k | 0.13% $ 152.2k | |
Founder | no data | US$818.06k | 0.020% $ 23.6k | |
Chief Operating Officer | 5.6yrs | US$651.09k | 0.041% $ 47.7k | |
Chief Financial Officer | 4.3yrs | geen gegevens | 0.27% $ 319.1k | |
Chief Technology Officer | 3.9yrs | US$633.35k | 0.012% $ 13.7k | |
Head of Legal & Compliance | no data | geen gegevens | geen gegevens | |
Head of People | 5.4yrs | geen gegevens | geen gegevens | |
Chief Medical Officer | 4.8yrs | geen gegevens | geen gegevens | |
Chief Revenue Officer | 5.5yrs | US$440.01k | 0.012% $ 13.7k | |
Senior Vice President of Engineering | less than a year | geen gegevens | geen gegevens | |
Chief Clinical AI Officer | less than a year | geen gegevens | geen gegevens |
4.8yrs
Gemiddelde duur
54yo
Gemiddelde leeftijd
Ervaren management: AUGX's management team is considered experienced (4.8 years average tenure).
Bestuursleden
Naam | Positie | Tenure | Compensatie | Eigendom |
---|---|---|---|---|
President | 6yrs | US$919.10k | 0.13% $ 152.2k | |
Founder | 11.5yrs | US$818.06k | 0.020% $ 23.6k | |
Independent Director | 2.6yrs | US$181.29k | 0.33% $ 382.1k | |
Independent Non-Executive Chairman of the Board | 1.6yrs | US$548.26k | 0.044% $ 50.8k | |
Independent Director | 7.4yrs | US$200.00k | 0.15% $ 174.4k | |
Independent Director | 1.5yrs | US$128.44k | 0.084% $ 97.4k | |
Lead Independent Director | 2.6yrs | US$210.64k | 0.15% $ 174.4k | |
Independent Director | 3.4yrs | US$190.64k | 0.25% $ 291.7k |
3.0yrs
Gemiddelde duur
60yo
Gemiddelde leeftijd
Ervaren bestuur: AUGX's board of directors are considered experienced (3 years average tenure).